<SEC-DOCUMENT>0001428336-22-000004.txt : 20220222
<SEC-HEADER>0001428336-22-000004.hdr.sgml : 20220222
<ACCEPTANCE-DATETIME>20220222160837
ACCESSION NUMBER:		0001428336-22-000004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220222
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220222
DATE AS OF CHANGE:		20220222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		22658115

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hqy-20220222.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ace1af5a-70a3-488e-ac1c-e7197ebcd6f4,g:1a5384c6-2ccd-4ffc-8da3-ec4af571bac8,d:31f8ddf31af84ebe8be2c9d52d8f0e79--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hqy-20220222</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV80L2ZyYWc6ZjY3ZTExNmZjYzVhNGFhZDg2ZmIwMmYyNDFkNTIxMjUvdGFibGU6ZjU0MDIxN2ZmMDY2NDkxZmFhMTMzNjViNGNlMGJjMWMvdGFibGVyYW5nZTpmNTQwMjE3ZmYwNjY0OTFmYWExMzM2NWI0Y2UwYmMxY18yLTEtMS0xLTI1MTE4_e20ca0b7-1a61-4c14-850a-28239d6fdebd">0001428336</ix:nonNumeric><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV80L2ZyYWc6ZjY3ZTExNmZjYzVhNGFhZDg2ZmIwMmYyNDFkNTIxMjUvdGFibGU6ZjU0MDIxN2ZmMDY2NDkxZmFhMTMzNjViNGNlMGJjMWMvdGFibGVyYW5nZTpmNTQwMjE3ZmYwNjY0OTFmYWExMzM2NWI0Y2UwYmMxY18zLTEtMS0xLTI1MTE4_7a204f5d-1918-4594-97a3-f45f341aeb58">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hqy-20220222.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-22</xbrli:startDate><xbrli:endDate>2022-02-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i31f8ddf31af84ebe8be2c9d52d8f0e79_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">Form <ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV84Mw_2fcdd25f-967d-4793-9b47-4ab348276cc9">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Date of Report (Date of earliest event reported)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yMjU_801a03bb-2006-4362-a8aa-8f564000dea7">February 22, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZDJlODRjNGZmNTcxNDJkZjk1NGYyYzUxNWJiMTY4OGMvdGFibGVyYW5nZTpkMmU4NGM0ZmY1NzE0MmRmOTU0ZjJjNTE1YmIxNjg4Y18xLTAtMS0xLTI1MTE4_6b33e390-0ef5-4256-9d1a-8931598cc030">HEALTHEQUITY, INC.</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZThjNDE0ZjY5NTcyNDQ2YmIyOTc1ODA3NDg1MzE3MmEvdGFibGVyYW5nZTplOGM0MTRmNjk1NzI0NDZiYjI5NzU4MDc0ODUzMTcyYV8wLTAtMS0xLTI1MTE4_fb457c91-d563-402c-8fc8-b1381b4f3bfd">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZThjNDE0ZjY5NTcyNDQ2YmIyOTc1ODA3NDg1MzE3MmEvdGFibGVyYW5nZTplOGM0MTRmNjk1NzI0NDZiYjI5NzU4MDc0ODUzMTcyYV8wLTItMS0xLTI1MTE4_377d296d-e0c8-472c-958e-b76059cead00">001-36568</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZThjNDE0ZjY5NTcyNDQ2YmIyOTc1ODA3NDg1MzE3MmEvdGFibGVyYW5nZTplOGM0MTRmNjk1NzI0NDZiYjI5NzU4MDc0ODUzMTcyYV8wLTQtMS0xLTI1MTE4_6d3a6ee8-b900-4ce4-9b4b-776785761c68">52-2383166</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification Number)</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yMzU_ce9075c6-92c7-426d-b693-4178da371b7e">15 West Scenic Pointe Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yMzk_8d14f93d-b6fd-4dfd-a96e-e54bcf5f987a">Suite 100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNDM_636dd7ed-3fd0-4f61-baad-4caf46098226">Draper</ix:nonNumeric>, <ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNDc_4bf7affa-1f09-4d33-9ae4-ab5e01448e51">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNTA_d7c602b3-ee98-4624-97fc-3498a42e470b">84020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNTU_704937ea-03eb-43c1-b3ff-835bd8d09060">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNTk_44ee1feb-0cba-45f8-9dee-1377b8fbb1ef">727-1000</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant&#8217;s Principal Executive Offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV82NjY_64e14d39-cbbe-4915-bd2c-49728867d421">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV83NTU_af7a2081-25d3-4f2f-adf4-568f32a71236">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV84NDU_8099136a-b87c-4478-98e6-0efdc5af820b">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV85NTE_2998b5ac-78e2-4ca7-887e-215987019248">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6MGE5NjFmMDk0NTgzNDc3NGJjNGFkZWJkN2Y3MzUxZWUvdGFibGVyYW5nZTowYTk2MWYwOTQ1ODM0Nzc0YmM0YWRlYmQ3ZjczNTFlZV8xLTAtMS0xLTI1MTE4_4180e43d-60d2-434b-89d6-9b5258543d64">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6MGE5NjFmMDk0NTgzNDc3NGJjNGFkZWJkN2Y3MzUxZWUvdGFibGVyYW5nZTowYTk2MWYwOTQ1ODM0Nzc0YmM0YWRlYmQ3ZjczNTFlZV8xLTEtMS0xLTI1MTE4_77972272-9953-4a7a-9770-913947a96083">HQY</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6MGE5NjFmMDk0NTgzNDc3NGJjNGFkZWJkN2Y3MzUxZWUvdGFibGVyYW5nZTowYTk2MWYwOTQ1ODM0Nzc0YmM0YWRlYmQ3ZjczNTFlZV8xLTItMS0xLTI1MTE4_b68ab177-1b37-4c26-b117-5a2eff1d7c3a">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8xMzY0_9702f114-7cb9-426c-a010-4b4c4ace063e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%"> </span></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:138%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:138%">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2022, HealthEquity, Inc. (the &#8220;Company&#8221;) issued the press release attached as Exhibit 99.1 to this current report on Form 8-K.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pressrelease-fy22salesmetr.htm">Press release issued by HealthEquity, Inc. dated February 22, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted in Inline XBRL)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:49.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HEALTHEQUITY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 22, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Tyson Murdock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyson Murdock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease-fy22salesmetr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia2c91723ecab411a9cbb4f91830d2705_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">HealthEquity Reports Record HSA Sales, Asset Growth</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raises Revenue Outlook </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Draper, Utah &#8211; February 22, 2022 &#8211; HealthEquity, Inc. (NASDAQ&#58; HQY) (&#34;HealthEquity&#34; or the &#34;Company&#34;), the nation's largest health savings account (&#34;HSA&#34;) non-bank custodian, today announced HSA Assets and Total Accounts as of its fiscal year ended January&#160;31, 2022. The Company also announced updated FY22 guidance and FY23 revenue guidance.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total number of HSAs as of January&#160;31, 2022 was 7.2 million, an increase of 25%, from 5.8 million as of January&#160;31, 2021. The Company closed its fiscal year 2022 with 14.4 million Total Accounts, an increase of 12%, from 12.8 million as of January&#160;31, 2021. HSA Assets grew to $19.6 billion as of January&#160;31, 2022, an increase of 37% from $14.3 billion a year earlier.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Team Purple, our partners and clients helped more Americans connect health and wealth than ever before in fiscal 2022&#8221;, said President and CEO Jon Kessler. &#8220;Adding more than 900,000 new HSAs organically plus 700,000 through consolidating acquisitions and our members growing their HSA assets 37% to nearly $20 billion, positions HealthEquity to deliver another year of HSA market share growth.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Accounts (unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.027%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSAs</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,207&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,782&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New HSAs from sales - Quarter-to-date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New HSAs from sales - Year-to-date</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">918&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New HSAs from acquisitions - Year-to-date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">740&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n&#47;a</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSAs with investments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">455&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CDBs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,192&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,028&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Accounts</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,399&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,810&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Total Accounts - Quarter-to-date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,326&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,659&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Total Accounts - Year-to-date</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,450&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,604&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HSA Assets (unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.027%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA cash with yield (1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,934&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,875&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA cash without yield (2)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(96)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA cash</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,943&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,119&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA investments with yield (1)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,668&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,078&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA investments without yield (2)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA investments</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,675&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,216&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA Assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,618&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average daily HSA cash with yield - Year-to-date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,465&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,599&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average daily HSA cash with yield - Quarter-to-date</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,084&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,060&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">(1) HSA Assets that generate custodial revenue.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) HSA Assets that do not generate custodial revenue.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business outlook</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended January&#160;31, 2022, the Company revised its previously provided outlook as follows&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue in the range of $754 million to $756 million&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss in the range of $54 million to $53 million&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA in the range of $232 million to $235 million&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-GAAP net income in the range of $108 million to $110 million&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-GAAP net income per diluted share in the range of $1.30 to $1.33 (based on an estimated 83 million diluted weighted-average shares outstanding).</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provided fiscal year 2023 revenue guidance in the range of $815 million to $830 million, which assumes a rate on HSA cash of approximately 1.55%.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Non-GAAP financial information&#8221; below for definitions of our Adjusted EBITDA and non-GAAP net income. A reconciliation of the non-GAAP financial measures used throughout this release to the most comparable GAAP financial measures is included with the financial tables at the end of this release.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:138%">Conference call</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HealthEquity management will host a conference call at 4&#58;30 pm (Eastern Time) on Tuesday, February 22, 2022 to discuss the fiscal 2022 sales metrics. The conference call will be accessible by dialing 844-791-6252, or 661-378-9636 for international callers, and referencing conference ID 9791554. A live audio webcast of the call will also be available on the investor relations section of our website at http&#58;&#47;&#47;ir.healthequity.com.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP financial information </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our financial information presented on a GAAP basis, we disclose non-GAAP financial measures, including Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per diluted share.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA is adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, and other certain non-operating items.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-GAAP net income is calculated by adding back to GAAP net income (loss) before income taxes the following items&#58; amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, and losses on extinguishment of debt, and subtracting a non-GAAP tax provision using a normalized non-GAAP tax rate.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-GAAP net income per diluted share is calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP and should not be considered as a substitute for, or superior to, GAAP results. We believe that these&#160;non-GAAP&#160;financial measures provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. The Company cautions investors that non-GAAP financial information, by its nature, departs from GAAP&#59; accordingly, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies. In addition, while amortization of acquired intangible assets is being excluded from non-GAAP net income, the revenue generated from those acquired intangible assets is not excluded. Whenever we use these non-GAAP financial measures, we provide a reconciliation of the applicable non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of the non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed in the tables below.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About&#160;HealthEquity</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for our more than 14 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable &#8220;Purple&#8221; service. For more information, visit www.healthequity.com.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-looking statements </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words &#8220;may,&#8221; &#8220;believes,&#8221; &#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;aims,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;should,&#8221; &#8220;assumes,&#8221; &#8220;continues,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;future&#8221; and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the ongoing COVID-19 pandemic on the Company, its operations and its financial results&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to realize the anticipated financial and other benefits from combining the operations of WageWorks and Further with our business in an efficient and effective manner&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to integrate the Further business successfully&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits&#59; </font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the significant competition we face and may face in the future, including from those with greater resources than us&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on the availability and performance of our technology and communications systems&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on partners and third-party vendors for distribution and important services&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth&#59;</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our brand and other intellectual property rights&#59; and</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on our management team and key team members.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.</font></div><div style="margin-top:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investor Relations Contact</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard Putnam</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">801-727-1209</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rputnam&#64;healthequity.com</font></div><div style="margin-top:13pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:13pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of net loss outlook to Adjusted EBITDA outlook (unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook for the year ending</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$(54) - (53)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16) - (14)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger integration expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition costs</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$232 - 235</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of net loss outlook to non-GAAP net income outlook (unaudited)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook for the year ending</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$(54) - (53)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16) - (14)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss before income taxes - GAAP</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(70) - (67)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger integration expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition costs</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on equity securities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total adjustments to income (loss) before income taxes - GAAP</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes - Non-GAAP</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144 - 147</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax provision - Non-GAAP (1)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36 - 37</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP net income</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108 - 110</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted-average shares</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP net income per diluted share (2)</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.30 - 1.33</font></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">The Company utilizes a normalized non-GAAP tax rate to provide better consistency across the interim reporting periods within a given fiscal year by eliminating the effects of non-recurring and period-specific items, which can vary in size and frequency, and which are not necessarily reflective of the Company&#8217;s longer-term operations. The normalized non-GAAP tax rate applied to each period presented was 25%. The Company may adjust its non-GAAP tax rate as additional information becomes available and in conjunction with any other significant events occurring that may materially affect this rate, such as merger and acquisition activity, changes in business outlook, or other changes in expectations regarding tax regulations.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Non-GAAP net income per diluted share may not calculate due to rounding of non-GAAP net income and diluted weighted-average shares.</font></div><div style="margin-bottom:3pt;margin-top:13pt;padding-left:13.5pt;text-indent:-13.5pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain terms</font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definition</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A financial account through which consumers spend and save long-term for healthcare on a tax-advantaged basis.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CDB</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consumer-directed benefits offered by employers, including flexible spending and health reimbursement arrangements (&#8220;FSAs&#8221; and &#8220;HRAs&#8221;), Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) administration, commuter and other benefits.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA member</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consumers with HSAs that we serve.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA Assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA members' deposits with our federally insured custodial depository partners and custodial cash placed in annuity contracts with our insurance company partners. Total HSA Assets also includes HSA members' investments in mutual funds through our custodial investment fund partner.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Our employer clients.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Accounts</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The sum of HSAs and CDBs on our platforms.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client-held funds</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deposits held on behalf of our Clients to facilitate administration of our CDBs.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Network Partner</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Our health plan partners, benefits administrators, and retirement plan recordkeepers.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, and other certain non-operating items.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP net income</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Calculated by adding back to GAAP net income (loss) before income taxes the following items&#58; amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, and losses on extinguishment of debt, and subtracting a non-GAAP tax provision using a normalized non-GAAP tax rate.</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP net income per diluted share</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding.</font></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hqy-20220222.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ace1af5a-70a3-488e-ac1c-e7197ebcd6f4,g:1a5384c6-2ccd-4ffc-8da3-ec4af571bac8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hqy="http://healthequity.com/20220222" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20220222">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20220222_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20220222_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://healthequity.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hqy-20220222_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ace1af5a-70a3-488e-ac1c-e7197ebcd6f4,g:1a5384c6-2ccd-4ffc-8da3-ec4af571bac8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_00d5dab0-15b8-49df-a6e7-8ebd25668600_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ab0e2d7c-759a-4315-a9f3-18f53fa5e49b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0c16397d-deca-4ce3-93cf-194db6a0c2c6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fb3ce8eb-4257-482d-be6b-b95d87041296_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_054c3740-2100-48e8-bbc7-f1f7da3a572e_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_aa192656-3ec8-4b02-9e5b-24a9dd744123_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f412b58c-42ad-46d6-9e15-810a4297f995_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3cbf4075-ca2e-4517-9d1f-d10db8f443b8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_92636bcb-3bb4-44ab-bf46-87c02a8a492d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_afaf3cb6-fdc8-4896-9b05-08435231c38e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e769de40-2f04-41dc-b401-a87692fbe10b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_be674bfd-3b6f-4753-a6bc-2eda41aa2ab4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_49b5ea7c-2c79-46cc-a1b3-a96a8e35f069_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_cb98370b-24ae-4a8b-aff1-21858db4d59d_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c4708597-1315-49a0-abf6-9d89b8a901d3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_3cb898f0-40db-407d-ac38-08e2e7b569ce_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f803f4b9-734f-4592-a472-9047658f10b1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0d0ca0e6-cca1-44fe-807b-d6ceb48a9aad_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_2dbad76f-aa45-4ebe-9d79-7292dd8ebfcf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_97470b1d-9aeb-4cae-86ec-644018c277a1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3ef7872e-46b8-461d-ba1d-0a3ab7b6b7da_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_18af07ea-5755-4852-945b-edff04686781_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c8479e82-513f-4062-9ee1-2415f7251053_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_15a5dbcf-8dda-4876-b60e-a109873621bc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hqy-20220222_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ace1af5a-70a3-488e-ac1c-e7197ebcd6f4,g:1a5384c6-2ccd-4ffc-8da3-ec4af571bac8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20220222.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_53af0a99-a2f3-4751-97fd-73f2528871a1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_DocumentType_53af0a99-a2f3-4751-97fd-73f2528871a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9724bd61-1493-446a-aeb2-d4f3bcf584cd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_DocumentPeriodEndDate_9724bd61-1493-446a-aeb2-d4f3bcf584cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c4dd7d53-0a25-47eb-ba43-fa362ef7bd91" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityFileNumber_c4dd7d53-0a25-47eb-ba43-fa362ef7bd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9aec627a-27bb-4db7-8f4a-60cf6443cec4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityRegistrantName_9aec627a-27bb-4db7-8f4a-60cf6443cec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bff64b63-9b2a-4e95-89a2-c9402d2e341f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bff64b63-9b2a-4e95-89a2-c9402d2e341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d5628b86-4745-4903-be75-52809b3a614a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityTaxIdentificationNumber_d5628b86-4745-4903-be75-52809b3a614a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ee526872-bceb-4b90-aa07-26c668b5dcf8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityAddressAddressLine1_ee526872-bceb-4b90-aa07-26c668b5dcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_e6085793-04b3-4312-a596-d3e5ab5f386a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityAddressAddressLine2_e6085793-04b3-4312-a596-d3e5ab5f386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_27a9abca-518c-4e95-8544-9f28cafb3369" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityAddressCityOrTown_27a9abca-518c-4e95-8544-9f28cafb3369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ee5b65ad-e59c-4402-a32d-3789a20350a4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityAddressStateOrProvince_ee5b65ad-e59c-4402-a32d-3789a20350a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8e7f6c1f-4484-47da-9115-7944c9805b40" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityAddressPostalZipCode_8e7f6c1f-4484-47da-9115-7944c9805b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9f17f803-cc60-47d9-b9eb-cf953b77f6b0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_CityAreaCode_9f17f803-cc60-47d9-b9eb-cf953b77f6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e8632cdf-b309-4c69-a984-dbc980def076" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_LocalPhoneNumber_e8632cdf-b309-4c69-a984-dbc980def076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_0fc68ece-cccd-45ec-a72b-625cde351eae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_WrittenCommunications_0fc68ece-cccd-45ec-a72b-625cde351eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_48e1ceaf-1d00-4cbc-80d0-a72f7dff84dd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_SolicitingMaterial_48e1ceaf-1d00-4cbc-80d0-a72f7dff84dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9ad0f34c-78ff-4737-a30b-8954857b8723" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_PreCommencementTenderOffer_9ad0f34c-78ff-4737-a30b-8954857b8723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_97ad483f-ebfd-4220-b537-d15e0236d008" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_97ad483f-ebfd-4220-b537-d15e0236d008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ec2c4345-59cf-4c8b-89ab-8a2d30f70828" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_Security12bTitle_ec2c4345-59cf-4c8b-89ab-8a2d30f70828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_630beef3-84d4-40f6-a343-599c036c271c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_TradingSymbol_630beef3-84d4-40f6-a343-599c036c271c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9372cdf2-304f-4d90-b7b0-2800794be65f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_SecurityExchangeName_9372cdf2-304f-4d90-b7b0-2800794be65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3ef28d7d-e4da-4296-8a15-b93e4b807f33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityEmergingGrowthCompany_3ef28d7d-e4da-4296-8a15-b93e4b807f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_374b3a61-db59-4f9b-b901-69dc338984b1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_EntityCentralIndexKey_374b3a61-db59-4f9b-b901-69dc338984b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_07652b37-43c4-4b84-baa9-9a399919512f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8133f291-edb4-4141-a927-d50d0ca993d0" xlink:to="loc_dei_AmendmentFlag_07652b37-43c4-4b84-baa9-9a399919512f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140132782637208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 22,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHEQUITY, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>hqy-20220222_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hqy-20220222.xsd" xlink:type="simple"/>
    <context id="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2022-02-22</startDate>
            <endDate>2022-02-22</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV80L2ZyYWc6ZjY3ZTExNmZjYzVhNGFhZDg2ZmIwMmYyNDFkNTIxMjUvdGFibGU6ZjU0MDIxN2ZmMDY2NDkxZmFhMTMzNjViNGNlMGJjMWMvdGFibGVyYW5nZTpmNTQwMjE3ZmYwNjY0OTFmYWExMzM2NWI0Y2UwYmMxY18yLTEtMS0xLTI1MTE4_e20ca0b7-1a61-4c14-850a-28239d6fdebd">0001428336</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV80L2ZyYWc6ZjY3ZTExNmZjYzVhNGFhZDg2ZmIwMmYyNDFkNTIxMjUvdGFibGU6ZjU0MDIxN2ZmMDY2NDkxZmFhMTMzNjViNGNlMGJjMWMvdGFibGVyYW5nZTpmNTQwMjE3ZmYwNjY0OTFmYWExMzM2NWI0Y2UwYmMxY18zLTEtMS0xLTI1MTE4_7a204f5d-1918-4594-97a3-f45f341aeb58">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV84Mw_2fcdd25f-967d-4793-9b47-4ab348276cc9">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yMjU_801a03bb-2006-4362-a8aa-8f564000dea7">2022-02-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZDJlODRjNGZmNTcxNDJkZjk1NGYyYzUxNWJiMTY4OGMvdGFibGVyYW5nZTpkMmU4NGM0ZmY1NzE0MmRmOTU0ZjJjNTE1YmIxNjg4Y18xLTAtMS0xLTI1MTE4_6b33e390-0ef5-4256-9d1a-8931598cc030">HEALTHEQUITY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZThjNDE0ZjY5NTcyNDQ2YmIyOTc1ODA3NDg1MzE3MmEvdGFibGVyYW5nZTplOGM0MTRmNjk1NzI0NDZiYjI5NzU4MDc0ODUzMTcyYV8wLTAtMS0xLTI1MTE4_fb457c91-d563-402c-8fc8-b1381b4f3bfd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZThjNDE0ZjY5NTcyNDQ2YmIyOTc1ODA3NDg1MzE3MmEvdGFibGVyYW5nZTplOGM0MTRmNjk1NzI0NDZiYjI5NzU4MDc0ODUzMTcyYV8wLTItMS0xLTI1MTE4_377d296d-e0c8-472c-958e-b76059cead00">001-36568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6ZThjNDE0ZjY5NTcyNDQ2YmIyOTc1ODA3NDg1MzE3MmEvdGFibGVyYW5nZTplOGM0MTRmNjk1NzI0NDZiYjI5NzU4MDc0ODUzMTcyYV8wLTQtMS0xLTI1MTE4_6d3a6ee8-b900-4ce4-9b4b-776785761c68">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yMzU_ce9075c6-92c7-426d-b693-4178da371b7e">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yMzk_8d14f93d-b6fd-4dfd-a96e-e54bcf5f987a">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNDM_636dd7ed-3fd0-4f61-baad-4caf46098226">Draper</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNDc_4bf7affa-1f09-4d33-9ae4-ab5e01448e51">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNTA_d7c602b3-ee98-4624-97fc-3498a42e470b">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNTU_704937ea-03eb-43c1-b3ff-835bd8d09060">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8yNTk_44ee1feb-0cba-45f8-9dee-1377b8fbb1ef">727-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV82NjY_64e14d39-cbbe-4915-bd2c-49728867d421">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV83NTU_af7a2081-25d3-4f2f-adf4-568f32a71236">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV84NDU_8099136a-b87c-4478-98e6-0efdc5af820b">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV85NTE_2998b5ac-78e2-4ca7-887e-215987019248">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6MGE5NjFmMDk0NTgzNDc3NGJjNGFkZWJkN2Y3MzUxZWUvdGFibGVyYW5nZTowYTk2MWYwOTQ1ODM0Nzc0YmM0YWRlYmQ3ZjczNTFlZV8xLTAtMS0xLTI1MTE4_4180e43d-60d2-434b-89d6-9b5258543d64">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6MGE5NjFmMDk0NTgzNDc3NGJjNGFkZWJkN2Y3MzUxZWUvdGFibGVyYW5nZTowYTk2MWYwOTQ1ODM0Nzc0YmM0YWRlYmQ3ZjczNTFlZV8xLTEtMS0xLTI1MTE4_77972272-9953-4a7a-9770-913947a96083">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGFibGU6MGE5NjFmMDk0NTgzNDc3NGJjNGFkZWJkN2Y3MzUxZWUvdGFibGVyYW5nZTowYTk2MWYwOTQ1ODM0Nzc0YmM0YWRlYmQ3ZjczNTFlZV8xLTItMS0xLTI1MTE4_b68ab177-1b37-4c26-b117-5a2eff1d7c3a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222"
      id="id3VybDovL2RvY3MudjEvZG9jOjMxZjhkZGYzMWFmODRlYmU4YmUyYzlkNTJkOGYwZTc5L3NlYzozMWY4ZGRmMzFhZjg0ZWJlOGJlMmM5ZDUyZDhmMGU3OV8xL2ZyYWc6N2MwNDQ4Y2M3YmQ2NDQxYmFiMmM0YTFiYTc2OGM2N2UvdGV4dHJlZ2lvbjo3YzA0NDhjYzdiZDY0NDFiYWIyYzRhMWJhNzY4YzY3ZV8xMzY0_9702f114-7cb9-426c-a010-4b4c4ace063e">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M*\[ ,-P'\'ZAE-TWW'DX_W=&[S]02P,$%     @ $(%65)^@&_"Q @  X@P
M  T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?
ME5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=
MT*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G
M7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y
M*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W
M7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,
MDP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)
M"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!
MBEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_
MD/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H
M43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[
M:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y
M_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J6
M9? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE
M 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR.
M !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ $(%6
M5)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(
M,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5
MN %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;
M+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%
MR=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M    "  0@594&445]3<!   G @  #P   'AL+W=O<FMB;V]K+GAM;(U1T6["
M, S\E2H?L!:T(0U17D#;D*8-C8GWT+K4(HDKQX6-KY_;JAK27O:4W-FZW%T6
M%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q8;!EK '$NW2:9;/4
M6PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P.6/$ SJ4[]ST=P<F\1C0XQ7*W&0F
MB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7F?RTA]@S8@\?5HWD9I:I8(4<I=_H
M]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#BG/]3(U45%K"FHO40
M9.B1P74&0ZRQB28)UD-N5G0&3K;V"%TH?653#@%%G=W4Q7/4 6_*P>-HK(0*
M Y1OJA65UY**+2?=T>M,[Q\FCUI&Z]Q*N??P2K8<<XY_M/P!4$L#!!0    (
M !"!5E0D'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_
M[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ
M0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,
MEJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
M    "  0@59499!YDAD!  #/ P  $P   %M#;VYT96YT7U1Y<&5S72YX;6RM
MDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>
MO,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0
MP1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2H
MN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%
M.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D
M(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S6
M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( !"!5E0'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ $(%65# K
M>)+M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ $(%65)E<G",0!@  G"<  !,              ( !RP$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  0@594WJ=J/$T$  #:
M$   &               @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ $(%65)^@&_"Q @  X@P   T              ( !CPP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  0@594EXJ[',     3 @  "P
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52P4&      D "0 ^ @  YQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hqy-20220222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hqy-20220222.htm">hqy-20220222.htm</File>
    <File>hqy-20220222.xsd</File>
    <File>hqy-20220222_lab.xml</File>
    <File>hqy-20220222_pre.xml</File>
    <File>pressrelease-fy22salesmetr.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hqy-20220222.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "hqy-20220222.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20220222_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20220222_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20220222.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20220222",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20220222.htm",
      "contextRef": "i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://healthequity.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20220222.htm",
      "contextRef": "i4c6e5c9014814ccc9b5a4f50f107aced_D20220222-20220222",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001428336-22-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001428336-22-000004-xbrl.zip
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M !"!5E2;7656= (  (0'   0    :'%Y+3(P,C(P,C(R+GAS9,V56V_:,!2
MW_D57I[GW* %(J#26E6:Q"YBK=JWR3@GB45B!]LI\.]G&S(N+5N1]C I4ISC
M\QV?JS.Z65<E>@&IF.!C+_)##P&G(F4\'WN/#_=XX-U,.IW1!XR?/\VFZ$[0
MI@*NT:T$HB%%*Z8+])2"6J!,B@H]";E@+P3CB8-N1;V1+"\TBL,X/MV5":$0
MD>R*X'Y(NK@W&  F-*(8^M&P#W.:7F>]CWD2D:ONH$>O<4QIBGM91O$@-0#0
MGJ'[T9S0@3.Z5HFB!50$F<"X2M9J[!5:UTD0K%8K?]7UA<R#. RCX/G+](=3
M]7:Z)>.+(^WU7):M?C>PVW.BH%4OEIO?V@604A>P;)C>^%14@8W6/+&'B-:2
MS1L-]T)6=Y"1IM1CK^'+AI0L8Y":C)=@<WJD<+"MB<Q!?R45J-KDZQV'3CH(
MV52PJA92(_X*/<A%-!P.@[4-SD/;U$T%)=KUP]E<.'ULESB*<3?RURKU@G<=
M>VR(<:4)IW#)V>8+M]R_\&%?V,M\:+G+?7#&%% _%R]!"LQ6+L1A9"R\[80Z
M!]D%WM/'YQ/.A796K&0GJVO&,[$5&)$-(FDCF4'6SLVK87BC7=PK(9)*4?ZE
MMX):BAJD9J .!\D9*"1DAEYN<-O /TLR]XTCK<8K^\?5L-N!0:"<[@-I6;VI
M#:M,+4K8IN8_CKN6<&G<!E'F\G!EOC!\RS^8?<32L7<KS&_@.\F->U;^./M\
M_J)Q!^^!UFIK-X6,<>;Z+C0WK7D0WO\Y,'(DLN@H. 5.3#4*TF]\XM:GD>[@
MG<H?0$I*VI27<WNWSF([89O)W9P%QX.V_3X81B?8SOFD\PM02P,$%     @
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MGIH8?+U8=5O$K@Y\TB*3K(;(U,R3NU0]CV4WLZH!RHU-^6C&)K&X,?-;L;S
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M;<Z1$6WI2RM4=^;> ]GJN(.ANS.M=81W-VR/\ED^9TZ-6*QK!>(X#$+@&\4
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MVQ;I0"59?X#SU4D$-)UB3SP QF=$&;-87/U0(.4@KB1C; 1<3RI"(FZ0"%$
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MDO1!P+GE=4[J)9SW'L[U5L& _&(K__YIAUF/_BO^D?6[,Q*0^4:C:9M5V#]
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M;<8P8T&0H.AT,R).(1;C^8B\.=<YC8N?C6$(BN%;Y\V>CX9'M)\YF'&+S.U
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M:FL6HYS;"M/+!&)$ 4(V^1;>0RB]6<_OS7IYP)<.K>=U:!4/XJ4Q?*LJ=?$
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MP$IG**U_Q )EJ(SI68W%GH"CG&P:$M "F5J0Z30)\8RTK1,UF2\1,&L1<#W
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MG:OB ^C]G>$!&#:B@>*PBQ4<?BE@;'=<_<?=))S /X-T&/WT_U!+ 0(4 Q0
M   ( !"!5E3E"*RQ6A0  #5_   0              "  0    !H<7DM,C R
M,C R,C(N:'1M4$L! A0#%     @ $(%65)M=959T @  A <  !
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?<VUE='(N:'1M4$L%!@     %  4 3 $  +!'      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
